The impact of insurance type on listing status and wait-list mortality of patients with left ventricular assist devices as bridge to transplantation.

ESC Heart Failure
Alexandros BriasoulisPaulino Alvarez

Abstract

Adequate health insurance coverage is necessary for heart transplantation (HT) candidates. Prior studies have suggested inferior outcomes post HT with public health insurance. We sought to evaluate the effects of insurance type on transplantation rates, listing status and mortality prior to HT. Patients ≥18 years old with a left ventricular assist device implanted and listed with 1A status were identified in the United Network for Organ Sharing registry between January 2010 and December 2017, with follow-up through March 2018. Patients were grouped based on the type of insurance private/self-pay (PV), Medicare (MC), and Medicaid (MA) at the time of listing. We conducted multivariable competing risks regression analysis on listing status and mortality on the waiting list, stratified by insurance type at the time of listing. We identified 2604 patients listed in status 1A (PV: 51.4%, MC: 32.1%, and MA: 16.5%). MA patients were younger (43.5 vs. 56.4 for MC vs. 51.5 for PV, P < 0.001) and less frequently White (P < 0.001). The cumulative incidence of HT did not differ among the three insurance types (PV: 74.8%, MC 76.3%, and MA 71.1%, P = 0.14). The cumulative mortality on the waiting list prior to HT was not different among group...Continue Reading

References

Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Alexander S Goldfarb-RumyantzevRoss B Isaacs
Sep 28, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jeremiah G AllenChristian A Merlo
Oct 1, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jeremiah G AllenJohn V Conte
Aug 1, 2016·Heart, Lung & Circulation·Khadijah BreathettSakima Smith
Sep 15, 2016·Circulation. Cardiovascular Quality and Outcomes·Dmitry TuminDon Hayes
Jun 19, 2017·Heart & Lung : the Journal of Critical Care·Maan Isabella CajitaUNKNOWN BRIGHT Study Team
Aug 7, 2017·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Lars H LundUNKNOWN International Society for Heart and Lung Transplantation
Jan 3, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M ColvinB L Kasiske
Feb 16, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Lisa M PotterDavid A Axelrod
Dec 17, 2018·JACC. Heart Failure·Ersilia M DeFilippisMandeep R Mehra
Feb 28, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M ColvinB L Kasiske
Jun 14, 2019·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Autumn M ClemonsVeli K Topkara

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.